太极集团：全资子公司涪陵药厂拟转让持有的阿依达公司40%股份

Group 1 - The core point of the article is that Taiji Group is focusing on its main business by cleaning up its non-core assets, specifically planning to transfer 40% of its subsidiary's shares in Aida Company for a starting price of 10.8 million yuan [1] - Taiji Group's revenue composition for the year 2024 is as follows: industrial sector accounts for 56.82%, commercial sector for 54.42%, traditional Chinese medicine resources for 8.5%, health and international business for 3.72%, and other businesses for 1.22% [1] - As of the report, Taiji Group has a market capitalization of 10 billion yuan [1]